DnB Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $728K | Sell |
4,217
-770
| -15% | -$133K | ﹤0.01% | 631 |
|
2025
Q1 | $777K | Buy |
4,987
+1,401
| +39% | +$218K | ﹤0.01% | 635 |
|
2024
Q4 | $494K | Sell |
3,586
-403
| -10% | -$55.5K | ﹤0.01% | 662 |
|
2024
Q3 | $596K | Buy |
3,989
+642
| +19% | +$95.9K | ﹤0.01% | 651 |
|
2024
Q2 | $456K | Buy |
+3,347
| New | +$456K | ﹤0.01% | 658 |
|